• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Financial Services·BCVN.SW
Share

Banque Cantonale Vaudoise Stocks

CHF 133Last Updated 04.09.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

CHF 14.10B

CHF 133
Key Takeaways

Risk factor

Critical default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Banque Cantonale Vaudoise (BCV), founded in 1845 and headquartered in Lausanne, Switzerland, delivers an extensive array of financial services. Its operations extend across Vaud Canton, the rest of Switzerland, the European Union, North America, and other international markets. The institution provides essential banking products such as checking, savings, and retirement accounts, alongside credit and payment cards. Its lending solutions cover mortgages, personal, home, business, and construction loans, complemented by specialized financing for production equipment, working capital, and international trade. BCV also offers sophisticated financial services, including investments and financial planning, with an online platform facilitating trading activities. It provides cash management solutions and tools to hedge against exchange rate and interest rate fluctuations. Asset management services are a key offering, as are investment and hedging products like currencies, equities, bonds, derivatives, and structured instruments. The bank conducts market transactions in equities, fixed-income instruments, foreign exchange, and precious metals on behalf of its clientele. Further expanding its offerings, BCV provides life and disability insurance, comprehensive online banking, and wealth management services for high-net-worth individuals, encompassing tax, estate, and financial planning, as well as retirement, life insurance, and disability coverages. Serving retail and business customers, as well as public sector institutions, BCV maintains a robust physical presence with approximately 63 branches and 220 ATMs.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E. Editor's note: P/C

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of BCVN.SW is 130 and suggests 2.26% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

07.09.2026 14:56

OpenAI's new AI model pushed emerging market stocks to a two-month high

07.09.2026 14:10

Tyra shares are having their best day in 10 months. Investors are awaiting new data on its drug

07.09.2026 13:11

U.S. inflation, Apple's latest products, Oracle's earnings report: What Investors Need to Know This Week

07.09.2026 12:22

Brent surged to $98. U.S. officials said the nuclear deal with Iran might not go through

07.09.2026 10:53

Top Stories This Morning: The U.S. Has Left Open the Possibility of Withdrawing from the Iran Nuclear Deal; Anthropic Has Postponed Its IPO

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026